Dr. Aimee C. Garza, MD

Dr. Garza practices at The Center for Neurology and Neurophysiology, P.A. in Frisco, Texas.

Dr. Garza's NPI, 1487854667, was assigned on July 25, 2007. Dr. Garza graduated from Joe R. & Teresa Lozano Long School of Medicine in 2002. Dr. Garza holds Texas license M6629.

Dr. Garza's primary practice is The Center for Neurology and Neurophysiology, P.A., at 7000 Parkwood Blvd, Frisco, TX 75034 in Denton County. The practice phone is (214) 494-4424.

Dr. Garza's primary practice is The Center for Neurology and Neurophysiology, P.A. in Frisco, Texas. The medical group on file is The Center for Neurology and Neurophysiology, PA. Dmand AI also links Dr. Garza to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Garza practices. Vendor and product names are available with a free account.

Neurology is Dr. Garza's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Garza is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Garza is licensed in Texas.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Garza treats.

CMS data shows 289 Medicare services from Dr. Garza across 5 procedure codes in 2024, for 123 Medicare patients. Medicare paid $25,754 for them. Every service was in an office.

CMS counts 123 Medicare patients who saw Dr. Garza in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Garza's median patient age at 55, with 75% women.

In 2024, Dr. Garza wrote 3,419 Medicare Part D claims for 456 patients. 82% of them were for generic drugs. CMS names the drug for 3,106 of them, across 72 drugs with 11 or more claims each, at $1,045,616 in total drug cost. In 2023, CMS named 3,047 claims across 69 drugs.

CMS lists Dr. Garza as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 2,935 general payments to Dr. Garza from 105 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $52,287.

Dr. Garza graduated from Joe R. & Teresa Lozano Long School of Medicine in 2002.

Dr. Garza is in network with 23 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.